Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lignocaine for prevention of chronic postsurgical pain after elective caesarean section
ACTRN12620000203954Phase 2Suspended
- Sponsor
- The Royal Women's Hospital
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lidocaine in postoperative pain and Persistent postsurgical pain (PPSP) (2 arms), sponsored by The Royal Women's Hospital. Primary endpoints: Incidence of chronic postsurgical pain in the placebo group, Recruitment feasibility and 1 more. Started Feb 2020; status: suspended.
02
Drugs
lidocaine
03
Conditions
postoperative painPersistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on ACTRN12620000203954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000203954.